TR200201211T2 - Pulmoner hastalıkların tedavisi için metod ve terkipler. - Google Patents

Pulmoner hastalıkların tedavisi için metod ve terkipler.

Info

Publication number
TR200201211T2
TR200201211T2 TR2002/01211T TR200201211T TR200201211T2 TR 200201211 T2 TR200201211 T2 TR 200201211T2 TR 2002/01211 T TR2002/01211 T TR 2002/01211T TR 200201211 T TR200201211 T TR 200201211T TR 200201211 T2 TR200201211 T2 TR 200201211T2
Authority
TR
Turkey
Prior art keywords
treatment
compositions
methods
pulmonary diseases
diseases
Prior art date
Application number
TR2002/01211T
Other languages
English (en)
Turkish (tr)
Inventor
N. Goodfellow Peter
Nieman Richard
J. Torphy Theodore
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of TR200201211T2 publication Critical patent/TR200201211T2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TR2002/01211T 1999-11-02 2000-11-01 Pulmoner hastalıkların tedavisi için metod ve terkipler. TR200201211T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02

Publications (1)

Publication Number Publication Date
TR200201211T2 true TR200201211T2 (tr) 2002-08-21

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/01211T TR200201211T2 (tr) 1999-11-02 2000-11-01 Pulmoner hastalıkların tedavisi için metod ve terkipler.

Country Status (29)

Country Link
EP (1) EP1225866A4 (cs)
JP (1) JP2003513028A (cs)
KR (1) KR20020057988A (cs)
CN (1) CN1387404A (cs)
AP (1) AP2002002496A0 (cs)
AR (1) AR029189A1 (cs)
AU (1) AU1357501A (cs)
BG (1) BG106748A (cs)
BR (1) BR0015270A (cs)
CA (1) CA2388333A1 (cs)
CO (1) CO5261512A1 (cs)
CZ (1) CZ20021512A3 (cs)
DZ (1) DZ3225A1 (cs)
EA (1) EA200200518A1 (cs)
EC (1) ECSP003747A (cs)
HK (1) HK1049107A1 (cs)
HU (1) HUP0203152A3 (cs)
IL (1) IL149367A0 (cs)
MA (1) MA26841A1 (cs)
MX (1) MXPA02004350A (cs)
NO (1) NO20022057L (cs)
OA (1) OA12076A (cs)
PE (1) PE20011005A1 (cs)
PL (1) PL355261A1 (cs)
SK (1) SK7592002A3 (cs)
TR (1) TR200201211T2 (cs)
TW (1) TWI242431B (cs)
WO (1) WO2001032127A2 (cs)
ZA (1) ZA200203435B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL160271A0 (en) * 2001-09-19 2004-07-25 Altana Pharma Ag Pharmaceutical compositions containing pde4-inhibitors and nsaid
CZ2004516A3 (cs) * 2001-10-31 2004-08-18 Merckápatentágmbh Inhibitor fosfodiesterázy typu @Ź jeho kombinace s jinými drogami a jeho použití
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
CN1767828A (zh) * 2003-03-31 2006-05-03 协和发酵工业株式会社 医药组合物
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
EP1810692A1 (en) * 2004-10-13 2007-07-25 Kyowa Hakko Kogyo Co., Ltd. Remedies/preventives for chronic skin disease
RU2008119322A (ru) * 2005-10-19 2009-11-27 Рэнбакси Лабораториз Лимитед (In) Композиции ингибиторов фосфодиэстеразы iv типа
ES2702753T3 (es) 2010-01-05 2019-03-05 Microdose Therapeutx Inc Dispositivo de inhalación
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995000139A1 (en) * 1993-06-18 1995-01-05 Smithkline Beecham Corporation Compounds
DE4332041C2 (de) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
SE9801368D0 (sv) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
MXPA02004350A (es) 2002-11-07
AP2002002496A0 (en) 2002-06-30
JP2003513028A (ja) 2003-04-08
NO20022057D0 (no) 2002-04-30
WO2001032127A2 (en) 2001-05-10
HK1049107A1 (zh) 2003-05-02
ECSP003747A (es) 2002-05-23
CN1387404A (zh) 2002-12-25
CA2388333A1 (en) 2001-05-10
HUP0203152A3 (en) 2004-06-28
OA12076A (en) 2006-05-04
IL149367A0 (en) 2002-11-10
BR0015270A (pt) 2002-06-18
AU1357501A (en) 2001-05-14
SK7592002A3 (en) 2002-11-06
HUP0203152A2 (hu) 2003-01-28
EP1225866A4 (en) 2004-04-21
DZ3225A1 (fr) 2001-05-10
NO20022057L (no) 2002-06-27
KR20020057988A (ko) 2002-07-12
BG106748A (en) 2003-02-28
ZA200203435B (en) 2003-06-25
MA26841A1 (fr) 2004-12-20
EP1225866A2 (en) 2002-07-31
AR029189A1 (es) 2003-06-18
PE20011005A1 (es) 2001-09-28
PL355261A1 (en) 2004-04-05
EA200200518A1 (ru) 2002-10-31
CO5261512A1 (es) 2003-03-31
TWI242431B (en) 2005-11-01
CZ20021512A3 (cs) 2003-04-16
WO2001032127A3 (en) 2001-12-06

Similar Documents

Publication Publication Date Title
TR200100500T2 (tr) Pulmoner hastalıkların tedavisi için terapiler
UY28958A1 (es) Nuevos derivados de piridazin-3(2h)-ona
DE60143393D1 (de) Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür
BR0210904A (pt) Uso de inibidores de il-18 para o tratamento ou prevenção de sepse
BRPI0411825A (pt) inibidores de p38 quinase a base de heterociclo de 5 elementos
TR200102110T2 (tr) Astım için formoterol ve flütikazon propiyonat kombinasyonları.
BRPI0407922A (pt) derivados de isoquinolina e métodos de uso destes
WO2001083554A3 (en) Anti-inflammatory compounds and uses thereof
CY1108274T1 (el) Μακροβιο ομοιαζον με γλυκογονο πεπτιδιο 2 (glp-2) για την θεραπεια γαστρεντερικων ασθενειων και διαταραχων
BR0317572A (pt) Benzoxazinas e seus derivados como inibidores de pi3ks
EA200300293A1 (ru) Противовоспалительные конденсированные пирролокарбазолы
WO2003037271A3 (en) Compounds, pharmaceutical compositions and methods of use therefor
BR0008228A (pt) Composições de n-benzoil estaurosporinaespontaneamente dispersìveis
WO2003011274A3 (en) Use of a pde4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma
CY1105225T1 (el) Παραγωγα 5-β-σαπωγενινης και ψευδοσαπωγενινης και η χρηση τους στην αντιμετωπιση ανοιας
NO20060328L (no) Kombinasjon av mGluR2-antagonist og ACHE-inhibitor for behandiing av akutt og/eller kronisk neurologiske forstyrrelser
TR200201211T2 (tr) Pulmoner hastalıkların tedavisi için metod ve terkipler.
CR6824A (es) Derivados de arilmetilamina para uso como inhibidores de triptasa
WO2002076434A3 (en) Nicotinic receptor agonists for the treatment of inflammatory diseases
MXPA05009986A (es) Tratamiento de la enfermedad de alzheimer.
BRPI0411864A (pt) combinação de inibidores de src quinase e agentes quimioterápicos para o tratamento de doenças proliferativas
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
AP2003002753A0 (en) Use of salmeterol and fluticasone propionate combination
PT1268472E (pt) Inibidores 3-aminopirazolicos de cinases dependentes da ciclina
BR0008382A (pt) Formulação de liberação controlada para tratamento de copd